As of November 2024, NYMOX PHARM has a market cap of $19.59M. This makes NYMOX PHARM the world's 30176th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $37.34M | -32.14% |
2023 | $55.03M | 84.38% |
2022 | $29.84M | -75.38% |
2021 | $121.24M | -47.58% |
2020 | $231.30M | 12.73% |
2019 | $205.18M | 67.94% |
2018 | $122.18M | -60.30% |
2017 | $307.77M | 23.60% |
2016 | $249.02M | -18.60% |
2015 | $305.91M | 720.00% |
2014 | $37.31M | -93.41% |
2013 | $566.12M | - |